OBJECTIVE: To assess the immune competence of patients presenting with septic shock by measuring on-line the production of intracellular cytokines by circulating leukocytes. DESIGN AND SETTING: Prospective study in a 18-bed medical intensive care unit of a university hospital. PATIENTS AND PARTICIPANTS: 21 patients with septic shock, and 11 volunteers. INTERVENTIONS: Single-step isolation of leukocytes from whole blood obtained within the first 24 h after admission. Leukocytes were fixed immediately or after treatment with lipopolysaccharide (LPS) and/or heterologous plasma. MEASUREMENTS AND RESULTS: Leukocytes were permeabilized, and the intracellular cytokine expression of TNF-alpha and IL-10 was quantified by immunostaining and flow cytometry. LPS treatment significantly increased monocyte intracellular cytokine TNF-alpha and IL-10 as well as lymphocyte intracellular cytokine IL-10 in normal leukocytes. Septic monocytes and granulocytes had nonstimulated intracellular cytokine TNF-alpha concentrations lower than those measured in volunteers and were severely hyporesponsive to LPS. These phenotypic changes were correlated with disease severity and could be reproduced by treatment of normal leukocytes with plasma from patients with septic shock. CONCLUSIONS: Intracellular cytokine staining is a simple and rapid method to assess in situ and on-line the inflammatory balance and responsiveness of leukocyte subpopulations and could therefore represent a useful monitoring tool to assess the immune competence of critically ill patients. This study identifies the cellular source of cytokines in whole blood and confirms prior reports showing that septic phagocytes are characterized by a predominant anti-inflammatory phenotype, with hyporesponsiveness to LPS, depending on a plasma deactivation factor.
OBJECTIVE: To assess the immune competence of patients presenting with septic shock by measuring on-line the production of intracellular cytokines by circulating leukocytes. DESIGN AND SETTING: Prospective study in a 18-bed medical intensive care unit of a university hospital. PATIENTS AND PARTICIPANTS: 21 patients with septic shock, and 11 volunteers. INTERVENTIONS: Single-step isolation of leukocytes from whole blood obtained within the first 24 h after admission. Leukocytes were fixed immediately or after treatment with lipopolysaccharide (LPS) and/or heterologous plasma. MEASUREMENTS AND RESULTS: Leukocytes were permeabilized, and the intracellular cytokine expression of TNF-alpha and IL-10 was quantified by immunostaining and flow cytometry. LPS treatment significantly increased monocyte intracellular cytokine TNF-alpha and IL-10 as well as lymphocyte intracellular cytokine IL-10 in normal leukocytes. Septic monocytes and granulocytes had nonstimulated intracellular cytokine TNF-alpha concentrations lower than those measured in volunteers and were severely hyporesponsive to LPS. These phenotypic changes were correlated with disease severity and could be reproduced by treatment of normal leukocytes with plasma from patients with septic shock. CONCLUSIONS: Intracellular cytokine staining is a simple and rapid method to assess in situ and on-line the inflammatory balance and responsiveness of leukocyte subpopulations and could therefore represent a useful monitoring tool to assess the immune competence of critically illpatients. This study identifies the cellular source of cytokines in whole blood and confirms prior reports showing that septic phagocytes are characterized by a predominant anti-inflammatory phenotype, with hyporesponsiveness to LPS, depending on a plasma deactivation factor.
Authors: A P van den Berg; W N Twilhaar; W J van Son; W van der Bij; I J Klompmaker; M J Slooff; T H The; L H de Leij Journal: Transpl Int Date: 1998 Impact factor: 3.782
Authors: W Y Park; R B Goodman; K P Steinberg; J T Ruzinski; F Radella; D R Park; J Pugin; S J Skerrett; L D Hudson; T R Martin Journal: Am J Respir Crit Care Med Date: 2001-11-15 Impact factor: 21.405
Authors: D De Groote; P F Zangerle; Y Gevaert; M F Fassotte; Y Beguin; F Noizat-Pirenne; J Pirenne; R Gathy; M Lopez; I Dehart Journal: Cytokine Date: 1992-05 Impact factor: 3.861
Authors: Philip A Berry; Charalambos G Antoniades; Ivana Carey; Mark J W McPhail; Munther J Hussain; Edward T Davies; Julia A Wendon; Diego Vergani Journal: Intensive Care Med Date: 2010-12-16 Impact factor: 17.440
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2005-02-18 Impact factor: 17.440
Authors: Luis A Socha; John Gowardman; Diego Silva; Manuel Correcha; Nikolai Petrosky Journal: Intensive Care Med Date: 2006-01-26 Impact factor: 17.440
Authors: Enitan D Carrol; Alistair P J Thomson; Ashley P Jones; Graham Jeffers; C Anthony Hart Journal: Intensive Care Med Date: 2005-08-27 Impact factor: 17.440
Authors: Marek Nalos; Stephen Huang; Ronald Sluyter; Alamgir Khan; Brigitte Santner-Nanan; Ralph Nanan; Anthony S McLean Journal: Intensive Care Med Date: 2008-06-03 Impact factor: 17.440
Authors: Masja Leendertse; Rob J Willems; Ida A Giebelen; Sandrine Florquin; Petra S van den Pangaart; Marc J Bonten; Tom van der Poll Journal: Intensive Care Med Date: 2009-02-17 Impact factor: 17.440
Authors: Tobias van Bremen; Daniel Drömann; Karin Luitjens; Christoph Dodt; Klaus Dalhoff; Torsten Goldmann; Bernhard Schaaf Journal: Diagn Pathol Date: 2013-02-15 Impact factor: 2.644